The American Diabetes Association’s Troubling Response to Criticism of Trump

.Text
The American Diabetes Association (ADA) faced widespread criticism after its leadership orchestrated the removal of five diabetes scientists from its annual conference in New Orleans, according to multiple reports. The incident, which occurred nearly a week before the publication of this article, involved law enforcement officers escorting the researchers out of the event after they distributed an editorial from the ADA’s own journal that criticized the Trump administration and funding practices at the National Institutes of Health (NIH).

.Text
The scientists, including former ADA president Irl Hirsch and University of Minnesota professor Aaron Kelly, were reportedly removed by police within minutes of beginning to distribute the April edition of the ADA’s journal. The editorial, which targeted the Trump administration and Robert F. Kennedy Jr.’s influence over federal health agencies, was deemed controversial enough by the ADA to prompt law enforcement intervention. Louisiana State Police confirmed to media outlets that they acted at the request of the ADA, which subsequently barred the researchers from the remainder of the conference.

.Text
The ADA initially stated that the scientists were removed for lacking prior approval to distribute materials at the event. In an email to members, the organization claimed the decision was “not because of the viewpoints expressed in those materials.” However, the association later cited federal 501(c)(3) nonprofit regulations, arguing that the incident was tied to maintaining a “strictly nonpartisan environment.” This explanation drew scrutiny, as the U.S. Internal Revenue Service (IRS) does not restrict nonprofit leaders from expressing political views in personal capacities or on public policy issues.

.Text
The incident sparked a rapid backlash from the scientific community. Within days, 40 medical professionals signed an open letter condemning the ADA’s actions, calling for an apology and an independent review of the organization’s policies. Another letter, circulated by researchers, similarly demanded accountability. The controversy escalated further when the ADA’s CEO, Charles Henderson, issued a public apology to the five scientists on Wednesday, acknowledging that the event “is not reflective of who I am, the values I hold, or the way I was raised.”

.Text
Henderson’s apology came after the editorial in question gained significant attention online, a phenomenon known as the Streisand Effect, where attempts to suppress information amplify its visibility. The ADA also announced plans to commission an independent review of the incident, though critics argued the gesture was insufficient. “This was a clear attempt to appease the Trump administration at a time when medical groups need to demonstrate leadership,” one researcher said, echoing broader concerns about the ADA’s handling of the situation.

.Text
The incident has raised questions about the intersection of political influence and scientific discourse. The editorial at the center of the controversy was published in the ADA’s journal, a publication that typically focuses on diabetes research and treatment. Its critical stance on federal health policies, however, appears to have triggered a response from the association’s leadership, which has not publicly addressed the specific claims in the editorial.

.Text
The ADA’s actions have also drawn comparisons to broader tensions between nonprofit organizations and political pressures. In 2023, the American Medical Association faced similar scrutiny after a similar incident involving a conference speaker’s remarks on public health policy. While the ADA’s response has been more extensive, the current controversy underscores the challenges nonprofits face in balancing advocacy, neutrality, and institutional survival.

.Text
As of June 13, 2026, the ADA has not provided a detailed timeline of events or released internal communications related to the decision to involve law enforcement. The organization’s leadership has faced calls for greater transparency, with some members suggesting that Henderson’s apology may not be enough to restore trust. “The damage to the ADA’s credibility is deep,” one observer said. “This isn’t just about a single incident—it’s about the values the organization claims to uphold.”

.Text
The episode highlights the complexities of navigating political dynamics in scientific and medical communities. While the ADA’s apology marks a step toward accountability, the long-term implications for the organization’s reputation and influence remain uncertain. For now, the incident serves as a cautionary tale about the risks of conflating institutional neutrality with political compliance.

.Text
Source
According to reporting from Science and Techdirt, the American Diabetes Association’s handling of the conference incident has drawn widespread criticism from the scientific community. The ADA’s CEO, Charles Henderson, issued a public apology to the five scientists involved, acknowledging the organization’s role in the controversy. The incident occurred during the ADA’s annual conference in New Orleans, where law enforcement officers escorted the researchers out after they distributed an editorial critical of the Trump administration and NIH funding practices.

.Text
Source
The editorial in question, published in the ADA’s journal, targeted the Trump administration and Robert F. Kennedy Jr.’s influence over federal health agencies. The ADA initially stated that the scientists were removed for lacking prior approval to distribute materials at the conference, but later cited federal nonprofit regulations as a justification. The association’s leadership has since faced calls for an independent review of the events and policies that led to the incident.

.Text
Source
The Streisand Effect, where attempts to suppress information increase its visibility, played a significant role in amplifying the controversy. The editorial, which had previously received limited attention, gained widespread traction after the ADA’s actions were reported. Open letters from medical professionals and public backlash further highlighted the tension between institutional policies and scientific freedom.